BIAF Stock Analysis: Buy, Sell, or Hold?
BIAF - bioAffinity Technologies, Inc. Common Stock
$1.14
-0.03 (-2.56%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BIAF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BIAF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $1.14, which is considered oversold relative to its 30-day fair value range of $1.20 to $1.34.
Technical Outlook: Technically, BIAF is in a downtrend. The price is currently testing key support at $1.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BIAF has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.00 (+412.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIAF is in a downtrend. The price is currently testing key support at $1.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BIAF has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.00 (+412.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.20 -
$1.34
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding BIAF? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 412.8% below Wall St target ($6.00)
- CAUTION: 5-day price weakness (-15.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.20 -
$1.34
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.11
Resistance Level
$1.48
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.14
Wall Street Target
$6.00
(+412.8%)
Revenue Growth (YoY)
-38.5%
Profit Margin
-217.5%
Last updated: January 31, 2026 2:44 PM ET
Data refreshes hourly during market hours. Next update: 3:44 PM
Data refreshes hourly during market hours. Next update: 3:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced BIAF Option Strategies
Professional options setups generated by AI based on today's BIAF price and gamma walls.
